Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Saffron Extract
Therapeutic Area : Ophthalmology
Study Phase : Undisclosed
Sponsor : Pharmactive Biotech Products S.L
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of AffronEye®/ Crocuvis+® on Dry Eye Syndrome
Details : Saffron Extract is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Dry Eye Syndromes.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
February 05, 2024
Lead Product(s) : Saffron Extract
Therapeutic Area : Ophthalmology
Highest Development Status : Undisclosed
Sponsor : Pharmactive Biotech Products S.L
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Saffron Extract
Therapeutic Area : Psychiatry/Psychology
Study Phase : Undisclosed
Sponsor : Université Catholique de Louvain
Deal Size : Inapplicable
Deal Type : Inapplicable
Evaluation of the Effect of a Combination of Plants to Regulate Mood
Details : Saffron Extract is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Mood Regulation.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
November 18, 2023
Lead Product(s) : Saffron Extract
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Undisclosed
Sponsor : Université Catholique de Louvain
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Saffron Extract
Therapeutic Area : Ophthalmology
Study Phase : Undisclosed
Sponsor : Pharmactive Biotech Products S.L
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of CROCUVIS+® on Computer Vision Syndrome, Sleep and Mood Disorders
Details : Saffron Extract is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Computer Vision Syndrome.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
January 27, 2022
Lead Product(s) : Saffron Extract
Therapeutic Area : Ophthalmology
Highest Development Status : Undisclosed
Sponsor : Pharmactive Biotech Products S.L
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Saffron Extract
Therapeutic Area : Ophthalmology
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : MACUSAFF (Crocin), Manufactured from 100 percent DNA certified Persian origin natural saffron extract improves retinal flicker sensitivity, blood flow, protects RGC, reduce intraocular pressure and supports natural mechanisms of the eye is introduce in I...
Product Name : Macusaff
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
January 21, 2022
Lead Product(s) : Saffron Extract
Therapeutic Area : Ophthalmology
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Saffron Extract
Therapeutic Area : Sleep
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
New Affron® Saffron Study Shows a Quick Effect on Sleep at Low Dosage
Details : The ingredient showed affron's effect in a single, low dose taken just one hour before bedtime, making affron a natural ingredient that is very easy to consume.
Product Name : Affron
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
August 31, 2021
Lead Product(s) : Saffron Extract
Therapeutic Area : Sleep
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Saffron Extract
Therapeutic Area : Sleep
Study Phase : Undisclosed
Sponsor : Université Catholique de Louvain
Deal Size : Inapplicable
Deal Type : Inapplicable
Evaluation of the Effects of Saffron Extract on Sleep Quality and Stress
Details : Saffron is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Sleep Initiation and Maintenance Disorders.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
February 11, 2021
Lead Product(s) : Saffron Extract
Therapeutic Area : Sleep
Highest Development Status : Undisclosed
Sponsor : Université Catholique de Louvain
Deal Size : Inapplicable
Deal Type : Inapplicable